|Comprehensive, easy to read, and clinically relevant, Bradley’s Neurology in Clinical Practice provides the most up-to-date information presented by a veritable “Who’s Who” of clinical neuroscience. Its unique organization allows users to access content both by presenting symptom/sign and by specific disease entities-mirroring the way neurologists practice. A practical, straightforward style; templated organization; evidence-based references; and robust interactive content combine to make this an ideal, dynamic resource for both practicing neurologists and trainees.|
|New to this edition|
- The latest advances in clinical neurogenetics, brain perfusion techniques for cerebrovascular disease, the relationship between neurotrauma and neurodegenerative disease, management strategies for levodopa-related complications in movement disorders, progressive neuropsychiatric disorders arising from autoimmune encephalitis, and more keep you at the forefront of your field.
- Reorganized table of contents which includes new chapters on: Brain Death, Vegetative, and Minimally Conscious States; Deep Brain Stimulation; Sexual Dysfunction in Degenerative and Spinal Cord Disorders; Sports and Performance Concussion; Effects of Drug Abuse on the Nervous System; and Mechanisms of Neurodegenerative Disorders.
- Regular online updates reflect the latest information on the diagnosis and treatment of neurologic diseases based on the latest recommendations and methodologies.
- Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, references, and videos from the book on a variety of devices.
|By Robert B. Daroff, MD, Professor, and Chair Emeritus; Department of Neurology; Case Western Reserve School of Medicine; University Hospitals Case Medical Center; Cleveland, OH, USA ; Joseph Jankovic, MD, Professor Neurology, Distinguished Chair in Movement Disorders, Director, Parkinson’s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX; John C Mazziotta, MD, PhD, Vice Chancellor of UCLA Health Sciences; Dean, David Geffen School of Medicine; CEO UCLA Health; University of California, Los Angeles; Los Angeles, CA, USA and Scott L Pomeroy, MD, PhD, Bronson Crothers Professor of Neurology; Director, Intellectual and Developmental Disabilities Research Center; Harvard Medical School; Chair, Department of Neurology; Neurologist-in-Chief; Boston Children’s Hospital; Boston, MA, USA|